Bio (AAVantgarde), a clinical-stage, biotechnology company pioneering therapies for inherited retinal diseases (IRDs), today announced the successful closing of a $141 million (€122 million) Series B ...
Krystal Biotech Inc. advanced stock charts by Barron's. View KRYS historical stock data and compare to other stocks, and exchanges.
Webcast event to begin at 8:00am ET on Wednesday, November 12, 2025 --CAMBRIDGE, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback